ESR1 polymorphisms were associated with aromatase inhibitors induced musculoskeletal symptoms in breast cancer patients. Jing F, Jiang L, Cao Y, Tian M, et al. Breast Cancer Res Treat 2026;216:28.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jing F, Jiang L, Cao Y, Tian M, et al. ESR1 polymorphisms were associated with aromatase inhibitors induced musculoskeletal symptoms in breast cancer patients. Breast Cancer Res Treat 2026;216:28.
PMID: 41848880